Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings

Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings

US Patent 8962692 · Granted Feb 24, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2024
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Riserless offshore production and storage system and related methods2023
Abuse deterrent formulations of amphetamine2022
Compositions and methods for treating celiac sprue disease2022
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2022
Ligands selective to alpha 6 subunit-containing GABAA receptors and their method2022
Compositions and methods of treating cognitive impairment2022
Compositions and methods for treating celiac sprue disease2021
Compositions and methods for treating celiac sprue disease2021
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2021